Unresectable Gastric Cancer

• CLINICAL_TRIALS research · 2024-12-31
  Clinical Trial Update: First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2) [Phase 2]

  Phase 2 study of RC48 plus sintilimab and S-1 as first-line therapy for advanced gastric cancer, including HER2-positive, metastatic, and un…

• CLINICAL_TRIALS trial_result · 2023-08-18
  Clinical Trial Update: A Single Arm, Phase II Exploratory Clinical Study of Pemitinib in Advanced Gastric Cancer With Previous Standard Therapy Failure the FGFR Variant [Phase 2]

  A single-arm Phase II exploratory trial of pemitinib in advanced gastric cancer with FGFR variant after standard therapy failure is being co…

• CLINICAL_TRIALS trial_result · 2019-10-09
  Clinical Trial Update: Low-Tox Vs Eox In Patients With Locally Advanced Unresectable Or Metastatic Gastric Cancer [Phase 3]

  A Phase 3 trial comparing Low-Tox vs Eox in locally advanced unresectable or metastatic gastric cancer was terminated.